King Olav V's Prize for Cancer Research 2025 to Karl-Johan Malmberg
Photo: Arne Thoresen
The Norwegian Cancer Society awards the King Olav V Cancer Research Prize each year to a researcher who has particularly promoted the quality of Norwegian cancer research. The prize was first awarded in 1992 and Karl-Johan Malmberg is the 34th winner of the prize, which amounts to one million NOK. He has been honoured with the prestigious prize for his groundbreaking work on how the body's own cells can detect and eliminate cancer. Malmberg is professor at the University of Oslo and head of the Natural Killer Cell Biology and Cell Therapy research group at the Institute for Cancer Research at Oslo University Hospital.
"It has been fun to follow the development of Malmberg's immunotherapy program based on NK cells towards clinical use. Malmberg has also had a fantastic professional development of his own research in tumor immunology, which has resulted, among other things, in him now leading a Center for Excellence in Research, PRIMA. We are very proud of Malmberg at the Institute for Cancer Research", says Kjetil Tasken, head of the Institute for Cancer Research at the Division of Cancer Medicine at OUH.
Links:
Kreftforeningen:
Fra fortvilelse til forskningspris (kreftforeningen.no)
Video (facebook.com/Kreftforeningen)
Institute of Clinical Medicine, University of Oslo:
Karl-Johan Malmberg Awarded King Olav V's Cancer Research Prize (med.uio.no)
Oslo Universitetssykehus:
Kreftforeningens forskningspris til Karl-Johan Malmberg (oslo-universitetssykehus.no)
Uniforum
UiO-professor tildelt Kong Olav Vs kreftforskningspris (uniforum.uio.no)
Forskning.no
Banebrytende kreftforsker vant prestisjetung pris (forskning.no)
Karl-Johan Malmberg - publications (ous-research.no)
Homepage of Karl-Johan Malmberg's research group:
Natural Killer Cell Biology and Cell Therapy (ous-research.no)
Department for Cancer Immunology (ous-research.no)
Institute for Cancer Research (ous-research.no)
Natural Killer cell biology and cell therapy (med.uio.no)
PRIMA - Precision Immunotherapy Alliance (prima.uio.no)